ロード中...
Treatment of CD30‐Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases
BACKGROUND. Cytotoxic therapy for relapsed and refractory germ cell tumors or metastatic sex cord stromal tumors is rarely effective and is often accompanied by high adverse event rates. Expression of CD30 has been observed in testicular cancers, and patients with CD30‐expressing embryonal carcinoma...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AlphaMed Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5905693/ https://ncbi.nlm.nih.gov/pubmed/29222199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0544 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|